A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NBP / 4-(p-nitrobenzyl)pyridine

[Related PubMed/MEDLINE]
Total Number of Papers: 71
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NBP  (>> Co-occurring Abbreviation)
Long Form:   4-(p-nitrobenzyl)pyridine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Aromatic Nitrogen Mustard-Based Autofluorescent Amphiphilic Brush Copolymer as pH-Responsive Drug Delivery Vehicle. CBL, HeLa, PEG
2018 Colorimetric Detection of Carcinogenic Alkylating Fumigants on Nylon-6 Nanofibrous Membrane. Part I: Investigation of 4-( p-Nitrobenzyl)pyridine as a "New" Sensing Agent with Ultrahigh Sensitivity. ---
2018 Preparation, characterisation and biological evaluation of new N-phenyl amidobenzenesulfonates and N-phenyl ureidobenzenesulfonates inducing DNA double-strand breaks. Part 3. Modulation of ring A. DSBs, PAB-SOs, PUB-SOs
2017 Synthesis of androstene oxime-nitrogen mustard bioconjugates as potent antineoplastic agents. ---
2015 Synthesis and Performance of a Biomimetic Indicator for Alkylating Agents. ---
2014 Alkylating potential of styrene oxide: reactions and factors involved in the alkylation process. SO
2012 Chemoassay screening of DNA-reactive mutagenicity with 4-(4-nitrobenzyl)pyridine - application to epoxides, oxetanes, and sulfur heterocycles. ---
2012 Connecting the chemical and biological reactivity of epoxides. 1,2-EB, AL, cis- and trans-2,3-EB, EP, PO
2012 Potential of the NBP method for the study of alkylation mechanisms: NBP as a DNA-model. ---
10  2012 Taurine-nitrite interaction as a precursor of alkylation mechanisms. ES, Tau
11  2011 Reactivity of p-nitrostyrene oxide as an alkylating agent. A kinetic approach to biomimetic conditions. AD, alk, pNSO
12  2010 Alkylating potential of oxetanes. DMOX, OLEDs, TMO
13  2010 Reactivity of the mutagen 1,4-dinitro-2-methylpyrrole as an alkylating agent. AD
14  2009 Improving the spectrophotometric determination of the alkylating activity of anticancer agents: a new insight into the mechanism of the NBP method. ---
15  2009 Sorbate-nitrite interactions: acetonitrile oxide as an alkylating agent. ACNO, AD
16  2008 Chemical reactivity and biological activity of diketene. ---
17  2007 Genotoxicity profiles of common alkyl halides and esters with alkylating activity. DEL
18  2007 New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis. BP, CBP, CoMFA, CYP2B6
19  2006 Autoxidative activation of the nematocide 1,3-dichloropropene to highly genotoxic and mutagenic derivatives: consideration of genotoxic/carcinogenic mechanisms. 1,3-DCP, 1,3-DCP-Ox, 2,3-DCPA, MMI
20  2005 Alkylating potential of potassium sorbate. alk
21  2004 Colorimetric high-throughput assay for alkene epoxidation catalyzed by cytochrome P450 BM-3 variant 139-3. ---
22  2001 Synthesis, antimicrobial, and alkylating properties of 3-phosphonic derivatives of chromone. ---
23  2000 Biologically stable [(18)F]-labeled benzylfluoride derivatives. BzCls
24  2000 Direct colorimetric method for determination of organophosphates in human urine. ---
25  1998 Albumin conjugates of the anticancer drug chlorambucil: synthesis, characterization, and in vitro efficacy. ---
26  1998 Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil. ---
27  1997 In vitro alkylating of alpha, beta-unsaturated amidoesters, diethyl pyridylmethylphosphonates and their cis-Pt(II)complexes. ---
28  1994 Reaction kinetics of alkyl epoxides with DNA and other nucleophiles. ---
29  1993 [Determination of glyciphosphoramide and its metabolite in plasma and the pharmacokinetics in rats after oral administration]. GPA
30  1992 Reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells. II. Enhancement of the alkylating activity of AZQ by NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase). thioTEPA
31  1992 Uroepithelial and nephrotubular toxicity in patients receiving ifosfamide/mesna: measurement of urinary N-acetyl-beta-D-glucosaminidase and beta-2-microglobulin. AUC, NAG
32  1991 Alkylating potency of nitrosated amino acids and peptides. ---
33  1991 Cyclophosphamide metabolism in the primary immune organs of the chick: assays of drug activation, P450 expression, and aldehyde dehydrogenase. AE, AHH, ALDH, CP, EROD, PAH, PB, TCB
34  1990 Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism. ---
35  1990 Nitrosation of aspartic acid, aspartame, and glycine ethylester. Alkylation of 4-(p-nitrobenzyl)pyridine (NBP) in vitro and binding to DNA in the rat. ---
36  1990 Nucleophilic selectivity and reaction kinetics of chloroethylene oxide assessed by the 4-(p-nitrobenzyl)pyridine assay and proton nuclear magnetic resonance spectroscopy. CAA, CEO, GCA
37  1990 One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase. MC, PB
38  1990 Structure-activity studies on organoselenium alkylating agents. Se
39  1989 The dependence of the mutagenicity of methanesulphonic acid esters in S. typhimurium TA100 on the alkylation mechanism. MMI, TFA
40  1988 Nucleophilic index value: implication in the protection by indole-3-carbinol from N-nitrosodimethylamine cyto and genotoxicity in mouse liver. ALT, I3C, MNU, NDMA, NIV
41  1987 1,2-Dibromo compounds. Their mutagenicity in Salmonella strains differing in glutathione content and their alkylating potential. DBE, DBP, DBPE
42  1987 In-vitro assays to detect alkylating and mutagenic activities of dietary components nitrosated in situ. ---
43  1987 Linear free energy relationships and cytotoxicities of para-substituted 2-haloethyl aryl selenides and bis(2-chloroethyl) selenides. ---
44  1987 Synthesis, chemical reactivity, and antileukemic activity of 5-substituted 6,7-bis(hydroxymethyl)pyrrolo[1,2-c]thiazole biscarbamates and the corresponding sulfoxides and sulfones. ---
45  1986 A simple conductimetric method as an alternative to the colorimetric p-nitrobenzylpyridine test for the measurement of the reactivity of potentially mutagenic alkylating compounds. TEA
46  1986 Activated phase II metabolites: comparison of alkylation by 1-O-acyl glucuronides and acyl sulfates. ---
47  1986 Comparison of the chemical reactivities and antineoplastic activities of alpha,beta-, alpha,beta'-, beta,beta'-, and alpha,alpha'-bis[[[(2-propylamino)carbonyl]oxy]methyl]-substituted pyrroles. ---
48  1986 Reaction of 1-O-acyl glucuronides with 4-(p-nitrobenzyl)pyridine. ---
49  1985 Effects of glutathione and ethylxanthate on mitomycin C activation by isolated rat hepatic or EMT6 mouse mammary tumor nuclei. MC
50  1985 In vitro mutagenicity of valepotriates. DH-VAL, VAL
51  1985 Mutagenic and alkylating activities of organophosphate impurities of commercial malathion. ---
52  1983 Mutagenicity of 3 structurally related epoxides, with defined stereochemical configuration, in Saccharomyces cerevisiae and in V79 Chinese hamster cells. ---
53  1983 Pharmacokinetics of melphalan in children following high-dose intravenous injection. HPLC
54  1983 Reactivity, SCE induction and mutagenicity of benzyl chloride derivatives. SCE
55  1983 Relationship of spontaneous chemical transformation of arylsulfonylhydrazones of 2-pyridinecarboxaldehyde 1-oxide to anticancer activity. ---
56  1982 Biliary elimination of cyclophosphamide in man. ---
57  1982 Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation. ---
58  1982 [Methodology of the colorimetric determination of alkylating cytostatics with 4-(4'-nitrobenzyl)pyridine (NBP) in plasma]. ---
59  1981 Alkylating properties and genetic activity of 4-vinylcyclohexene metabolites and structurally related epoxides. NTP
60  1981 Alkylation of guanosine and 4-(p-nitrobenzyl)-pyridine by styrene oxide analogues in vitro. DMSO, NSO, SO, VTO
61  1981 On interactions of cytostatic benzylidine hydrazines with SH-groups. DTNB, EAC, NPSH
62  1981 [On the methodology of the determination of alkylating activities of nitrogen mustards with nitrobenzylpyridine (NBP) in biological material (author's transl)]. ---
63  1980 Determination of reaction rate constants for alkylation of 4-(p-nitrobenzyl) pyridine by different alkylating agents. ---
64  1980 Effect of N-Alkyl chain length on the mutagenicity of N-nitrosated 1-naphthyl N-alkylcarbamates. ---
65  1979 Excretion patterns of alkylating metabolites in urine following cyclophosphamide treatment of tumor patients: influence of application route, dosage, liver and kidney function. CP
66  1976 [Selective photometric determination of aliphatic nitroolefines by means of 4-(4-nitrobenzyl)pyridin (NBP)]. ---
67  1975 The effect of plasma on the reaction of cyclophosphamide with 4(-p-nitrobenzyl)-pyridine. ---
68  1973 [Thin-layer chromatography demonstration of various alkylating phosphoric acid esters using 4-(p-nitrobenzyl)-pyridine (NBP) and piperidine]. ---
69  1971 [Thin-layer chromatography of alkylating compounds with 4-(4'-nitroboenzyl)-pyridine (NBP)]. ---
70  1969 [Identification of alkylating agents. II. Identification of different classes of alkylating agents by a modification of the color reaction with 4-(4-nitrobenzyl)-pyridine (NBP)]. ---
71  1965 [THE PREPARATION OF 4-(P-NITROBENZYL)-PYRIDINE (NBP). DEVELOPING AGENT OF ALKYLATING REAGENTS]. ---